[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "In the context of tumorigenesis, which genetic alteration listed below is most likely to lead to copy-neutral loss of heterozygosity, specifically maintaining the gene dosage despite allele deletion?\n\nAnswer Choices:\nA. Mitotic recombination\nB. A deletion of a chromosomal region\nC. Trisomy\nD. Uniparental disomy\nE. Duplication of a chromosomal region"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-o0HuTmd3avaTogjUBt1l",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Uniparental disomy (UPD) \u2014 this results when the remaining allele is duplicated after loss of the other, producing loss of heterozygosity without change in copy number (copy\u2011neutral LOH).\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Evaluating genetic mechanisms**\n\nI need to determine which genetic alteration could lead to copy-neutral loss of heterozygosity while keeping gene dosage stable despite allele deletion. Copy-neutral LOH happens when one allele is lost, and the remaining one is duplicated, preserving copy number. The main contenders are mitotic recombination and uniparental disomy (UPD). The question hints that UPD is the best fit since it maintains dosage after deletion. However, mitotic recombination can also create copy-neutral LOH. The prompt suggests UPD is the \"most likely\" option.**Clarifying mechanisms of LOH**\n\nI\u2019m looking at mitotic recombination, which can also lead to somatic copy-neutral LOH in cancers by creating two copies of one parental allele. The term \"uniparental disomy\" implies both copies come from one parent, typically resulting in copy-neutrality. The phrase \"despite allele deletion\" suggests that while one allele is lost, dosage is still maintained, which aligns with UPD. So, I conclude that the best answer is D since it preserves dosage unlike the other options that alter it. I'll prepare to return this in JSON format.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Evaluating genetic mechanisms**\n\nI need to determine which genetic alteration could lead to copy-neutral loss of heterozygosity while keeping gene dosage stable despite allele deletion. Copy-neutral LOH happens when one allele is lost, and the remaining one is duplicated, preserving copy number. The main contenders are mitotic recombination and uniparental disomy (UPD). The question hints that UPD is the best fit since it maintains dosage after deletion. However, mitotic recombination can also create copy-neutral LOH. The prompt suggests UPD is the \"most likely\" option.**Clarifying mechanisms of LOH**\n\nI\u2019m looking at mitotic recombination, which can also lead to somatic copy-neutral LOH in cancers by creating two copies of one parental allele. The term \"uniparental disomy\" implies both copies come from one parent, typically resulting in copy-neutrality. The phrase \"despite allele deletion\" suggests that while one allele is lost, dosage is still maintained, which aligns with UPD. So, I conclude that the best answer is D since it preserves dosage unlike the other options that alter it. I'll prepare to return this in JSON format.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSlUIQUaEM9wnKEPku8IBo3-g76f5Jj9sKr0RAGZJwHoj6VNHDC3ZEVl5gZUwMTo1CK-2Bh-OZfbCFtSha9UTX6yOm9tF_1qs5J_gdgC7STZBAz0ARjWpyFZ08M9mO6SbjsWnWWyLOW4auhC64sx21oBzD6aHnOzLY4xjI6H6P2HTVHTN8KhxTJxRihJBRwzNHJ-LmEQu78opo9bIofKJ6fJd4ZE1y771waeIGbbnSHkCGo0g_Mu4mP3Oh0K6ybq0gBd4sPpvU7ZfQwpEdtPqqXLklpVbsIItCjHs-li2ppSHdFjZ30Hq4dUADwqSml7E6lsGZM8smht2y-zdkRqBQ4xxcWeTpYZyiMnLl9X4AkmA6SL-vHEQZ4zT6hhx8ZRZl67yZPbCZrnu6Rb9b36iioUcE_ZfLKl6pTup9COpynC6iKbFPJtZcDbykdWtfgzYz3Nkyo4FrA4HjqlGfOl0-cAX0ba7LvrsXS4zCEnOJbkHI_XOvjNc14SDlZmGQwB9w6WnEjRJOPDoViHrAGhypUveH1L_h9Hau5I9MBctbVK_AV8fs88G5rESj-iVYpJpABXulSQEq0LE6-irJybh_zXRAEyFAlCnM3sSRsOXV0T0hg3SMQJesYqf7Z8W9-Of-qcPfJsb79RN7mNaHfUWAfG57tyKBemILOw3gtHBfn52qXGe1SAiV1oF9erdfaKUEAw4AuM2JtSDBZB_-qD99a2GSDWJT8rW3Dah83o99zqC6USfaYV2Qs1aycoRaTkKrZvzTrKV1SnxKXzXWKqPnUS5aUyiBW3-mfqNXSfnQB-OLnjx2JJ0-Rzd0880wtLpP1TLAKmPG7hzW2l4qWTZlpd8gM_eDrAhCnqEzE01uKdtS921e2-OPrc5Krcjd78VCX5JUKS--L5vsqwDxXNbm_rEKsmmgKTyTQFXl_aNqtcza9JE-oW59fqWoHD8lP6VAw6oeQpOatEnDN6ilTDWSlI-uo1039hojU46aCVjBf-cgBs49uSbPxuqaclICLerS9HnH1j4ThdIkrLtLQCvoEkwzhgT7gTexcHjMkLdWDAROd6qTa-FfQmCVHELrqZ2q23nESh03NuIjTXxFgAqecx6EAaaBl5NPukaVulijMmg7SDk6pkh2ub34Yupnmbqm9yDUUSfN1JaeTdOTX0NkcWs1UteijN7vTf7P30Ua3oDIgqUfnHsyQNTPlv4RcgqizQVqp90bLBm8sB5L77VLf2S_lCmJ0Qjae8X2d2j84JYx8xx_Bi92atgSysXXTcgxR53_X7wKvlSG6R2SazcS7b9e68LgcfyXvZP-YJNAO3nZUbEcGdgm_gTDbE2EKeuphhaM8UKpBN9jH4m2WjPBe6D0TMqt5nmPkWxFaTZoXBlloHzyVm-CBaL3JDYhFLWoppKnZRqRG855RUjBTK0mTQ4XdSzeRaQCZU1NxEHenzkS4Vr13UKvaXtnHlZ1BgXQ5YWWUmpeAxW37iiYvYQJBgzioRJA3GpCwoHpWXu0b4v8VqE_E8QCBcjyUtBBZNIGccIIbOaHh8aHEuhNjez_bAUCauarpNkXLKSChLUC7P-buu1fbB4I8xnunYp3nLzmChf4VbsdUgPFV0LN-Ul3hRWuKr-VCWFwp467AM93UkR0Xcgs3xBwNcKO6amVE0VJTR4ENqDNi-cLEhEbTstCpffnLlhIfnB2iqIiaevAHQfqq7DwdVlQguJsLQcwpdjaxg7vBx0J6RlTEjXDXDbhqVqKz8TZyt2tpddVQx9mIdZfo5JLWlUcKwJTQdgvx4CzcF-RpOb0RjXo-iced2N5WjmnaWQI5kRcb2Hk-xD2gs0aqTcPvOG30I5wrXb_sm4Rp5m4wNJATzkaBSVUR6hxBTpbguAXa54s0aBQWO4bsGvaqc8TXuJPinY8-rRYluoW1LiZ5MUp-PxxZTiFAuOo5Rdl7Qfh024p0YdX2p2xd7oglZhHALuc3vIE-GHcUEIGVvYqP8etfG9q7qg3V7z-ibQDumc_Rftqpy6G7Obma0ukZtbZsSZgqmiBwKO1kqDDr7OHRQoWdVzl-tpyEb3QZvt0nMIVCggz_9FZchqGJQAbXxhs1ZcOAy1T-pRhzM3TcUIAwI9k56GFpPqRLV48TT9ugoOu6r3EKNiZfKp3LOwzTQdH4fEDicDGfRQaJ0Ud0hkzWK9cGsWwY_T4ZKNHI87rEv-_gUWJEJP4SlykzruLtHQV2EnadflnuEL2CGNQ1oXht7B0LelYEv6zhoZuXkNbj2sFZaB3au6KS2eiH3SGXDGNCruF1iPm8Z0wK8pM3gF-C0t1i2vPdD4nRXy8222k2wwip2TIQQbmVnuuakjA7LMejA3Zljpufxp_h4QNXepgoT1Bpr7T68Kg6gaUYe4HW6SUeO7751sx8CgcBzeYqa4rwuH_Q1gZARkXZaEa5fdL4j13umz_oJ3gVNTJAog5rvR7X1XYBX3atwQW2VAWvaXDEgoRpw_obn_fyCGJKCqmWpT9fphKmcvKwMg7U2DgNJbNHiBuKOyugqfwJ0kGwZjfobbh0uzVFFS5XU3QPpwxPwrG60EnNO-1aiZ9FUzmNppl9Y4cJmRcrXVXZeO91XQXqTjhCXisE9fnfeU9wKiu9n4qOCTaUWib_fZ3rAzoU-SuSLEn-U2LJAznqkEkNzoYuMp-Sruy_CS7_z3MTzbbEIE0-KSA6NgdfZYR-yGLHr700TSO1MViw7UMGQwmgYCUyHpdZUP09FMULlveA-Qi31BMJ1dOm6Hkx7ZMYQJMD2nlXDEPP9o5Rk-fB5xN2QQGcPi92TNvm-h6nuzDT80zh6_SuDiTKbMj3BuQqJdK1xBzFHL6g70NcfxzynqNFa67oQf-gt4Cco3TU-x4bnGbfBqQ1647BLqeShfSScKr7-s4_colKwe2KgfVM07fqBmn5K232Uf7ftXsgWFt5ibqvdimXDAKlK8Tvf4juiwB7BNo9AAq6tiWIldGBlum1gbIxkuEE_zwJQf38lInny7QoBDakNF8fbl5hgEEGjuiltIWMvGhlNF9H1E4Ok7HmQoUvSuLcTav4y6YElvku4ZWFnzkrEBx3pGFpHaJHCB4a_GMKt-6kT_nQJS2qtwnJLD7QubjRwjo2Yiq5zXqa5WPfRy5g67-o5vzTtavgI-EtPkkdF1laDSJtxpFIEaqCHMhP_DYVKtVF6IDsY5vhEWgb-l8CI4GpNI2Gf4l0RXdC2C_dFus87pLU1hJeNIvNICCKplNchURfb7his_LAGrgz3wrxdlp3KHqVV6SluWt_nMRKD5Ygwn4armVD3ZtbWncppEAFpQW64BxjLqMcIwnOqeuxk3L6gbblpD37EZyIafG6skZiB4O_OxV2S2V9PdJUlG8dpPNXAFgNyxPj2lQ11Rx8_N8vxu5MmaWX_ZCXgE3mI9W6MCQhKxH5BWozt_2eknANno120DCrjTRxqFkjUseQL20_CBCPuqm4Jn-SeMwYomziSxU66Lkc-Glt0DYSEf1ROq6R0i5hDsHP1IL9nkOOx4nsb0rc19o4AEg==",
                "id": "rs_04a814cfa1dacbe6016909294a6918819789340afde06f54d4",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 448,
        "prompt_tokens": 129,
        "total_tokens": 577,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 384,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00092825,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.225e-05,
          "upstream_inference_completions_cost": 0.000896
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "In the context of tumorigenesis, which genetic alteration listed below is most likely to lead to copy-neutral loss of heterozygosity, specifically maintaining the gene dosage despite allele deletion?\n\nAnswer Choices:\nA. Mitotic recombination\nB. A deletion of a chromosomal region\nC. Trisomy\nD. Uniparental disomy\nE. Duplication of a chromosomal region"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-DAevr5jLm740AxSA64Fu",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Uniparental disomy. UPD (including somatic isodisomy) results in two copies of the same allele from one parental chromosome, producing loss of heterozygosity while maintaining normal copy number (copy\u2011neutral LOH).\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": null,
            "reasoning_details": [
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSlYMRkl4g1RaHsJfSj5nIhve22mfOgvB1QFhR17p2nImDb7itceUlEahUIXkmlavGEhPgjEokXOHeZv9wRcEvte60PYilod8lLVdkc9GhAljwc5QKhxkrwmdAV1YC25CAWUYIVDTI-cKb10ITpmx4q1txC3GuN1D2A0SzV1opxPzhLXnrY5FAAyQQ5ks_JKqU8gkoTdYQ1AszHaWv10brdVjVeMOLNZ9sZKNE1MwCwul9AcgHyDGTyN20Hhz6hqs9v2HCHhKt4-nsERb5eUNTfndxKrgf_pgzz-8wzNAx_ov3uxBo7QOtHBMVSbqh8MR83FriQoXW7WdT4_e64oTpbuhzVpgjDPXJsetMUWVQOyve3T3hUotKOJpXZmr4_sHKYo6GHGIkdOlSErtuINZ0YxLetx6GxzlrXUomFw0PfnQl8KhyFVtgVHJwu12JUl64Tpb0eKq2iIW1hlp1L2HjQsl5RO8YmmmAuYL8RuHUnQhLM536Kop-qt1l8yM0kwR2d9aWzukfre1KjNiqk5AuBT6uGNwH9z-RXNPqTvU7ne9zcUuXFAFdIkxzASYJyxDAop-cBStRdfOj20XIT27OnNfXRn3RkObKkTlXNy-j5lhx97zGRK2FcFph-uqd7UVFaNiepmztvKmoPhQRDBSmg5z2563D9IEj1h-jQBgOHOelA3YtsEsXvJpVrYc4DXfU2juFiRTM6QtoMkDHo4dydaiZB0PAiGaw6G_PwK8MQlg9C9bKHGJdjRkmU1islk1K9sbJjrfZF5K_53CM486fG5qKRxJ6VQoVT81CcPsh3JyUk8l5ICvdKJL08F7bp4UodoM4xeQ0L7sQ3ggc-HntWXxCTZPAosOUJjsgFiBrgBWMD5ajoa1lSwhc6giGuy1UXF6-VCpEYKAzTTQKnJafViUs4d9QHRB_Dcb_2XjYbM0Epykku-ZklxV7Sdcix1KL8wV3XWX4CavdTshUNNt2quJ2uysAZU2Rri2_Jm4xyrWwL8OaXuMq26YwfIKO-y24Pb-j3yUBdPR7e5xOjf29LOVbO6E6-fpd8wPdzhBjRVa66VTM_dxARl7k4suJF7IaHWG02LfCvtXkU0mqTH9oiidvu9E8A6P2RREwNIA3fGQfJy4qDWLvqiKkjNieNDNMYIxr3drMGgjUXLTgECrvScn1mPld21YLJLM5dd89MN95qYPH237984cuQudw4Uuwcnv6S_7Lp-ox0fI_budUzgcrmg9iAZniyZ6gJco7gs_5kGC0X5B15Gr9Y23x1sey7fGd1oNYgxOp9PaxKI-EO7lC2ETdB5oB7vW9TR8i5iOKV3VHi4k27n6y1egp7dg6V9avNJxaqHey9nns5TIA4Kvwu_q7MNz66Ho5ZnUBvJ4W5dzchlkt3k4BHjXWyTHfisB43IBgHBPY2ft0LW8HslufkuPU1Xm79sEzVNPB_hGBvfDMgVGbdsbjMAGHnutJRWHRenZFYBzxK3AUlrZZcIIGM1XVzIsyx9tRq1R15PAf8UE7WuFpUYplsFZH5JhQ2z0wMIFivjUxzHUo2spDrm4nXBtiVGsl1HU1soONQ67nZ-aV6H96rSBZDUyBDD-ISONVqBMzI1NkyDFtfT29mLJru_uZYgtTRQ6p92a1D1Q_4baYyNSLmM0Mgpe0E-Oc_cMe1VYinlu1F6W4Zphv_fw7gDAnqwF1jmwg7R_g05rszBUw3G8W7dxpevGbal6CgKKIjdA6DW1XMXyz6gW6lg4b1Etv_xUbh0FuWzpElV9809FJ6CyoKFyq72wu6LBzdywyOP7EO8OPxPQqQ6ggX5cfxQ4FGuXidFQH2l2mtRYmQ6U-RDKI-jN8nEa4bKY_HjY2ibQL2VoyMHoyBarUiyouzL_4-ZEktOoY3fCeViWkRHJESDrAMKFFT45QjPawSl-7h9BZcQXKrhPWvYM8pDVT5MAvIHaaTGS-z6w9nm8aUfZZUTuBl9MlTw1ombYh067Obbn0J_wCWLHXaSD1aWxrVapWB4Yd1GmuxsoLW5_WG90QSVA5vfWQXp4Jv8G6EOqxqiucPjxa4YaEgMCAJqPGZJNikRu_Str9dxgvsuMxRCrhQL3cadOxmiFM6nTOniZ9TrV0_G_H4FlJgRrl4nnpQ1BPiH-p4WUSC_coIZDIRHc7J6kdJtoFqe6-wOe0QYK8hE81uJ2Ub2xpYrmNM30evCb_SQ8FOQQkd65xzjMl91nOLHrebDfW2vdTgb-t41We639qw_6YSZBc03IVJkks2hkuDdsVc5gQtO8GuZ-iiG_s6Dl_cAXpqDLaPe8leVM0Ff5qMmpeJDa5p0CUaGsOI4tpP0WRv_45SBySkEBYyWt2zcfSH22yevaqAVlWytw_3TJ5mADtyIpRu764nJP43QRE-AmHYCMpfjFmjjTONMc_lZbFWpPH7REBdBNEW0l9kG9kdLpNO1pTWgbfb8hduX9zqHJWjmzltw8HvBlxaBxg_nLyz0sBWrtuFg7VKVhWQAIXbV4lwJGLo02j_6z5W8nt-1nzGfRLDZzgMEJpCjxJNgKP7ZxT2N7fgToRAIr65NqvlF8QMlpiyM7T92SWwzFQ-H2lVKAaOM68eL30MX9K6y88MYuAhk8ALvaYHevLibG-5ZJC3ZtQIDftKMtQ7Qo7aE2yk4FyYMtOhVYryEZtruD6cU7mTkxzFjYfcy_uk4F7LWP58PdS4Ck-bJFeGozLevREKHHEuL48fD_YN_eWWf_H8cXCqitnY7AQJFOOERwuzzN82DAXmyNpXnf8YveV4Xcth7aHsnhBYIWjKlTY9D8_YA2QBY53hsjpgV5LeMNbLDD55-QQX4NlC1z67kwPK6YlDwVWQnZ-QAwXYnQR5eAPQtuLuRXk7ov3fiKPGhe0tLzGaRD3SaxeSw6IkgWN0AYbaKdLMbdm-2eUQCM3Z9mnmh1xiYnEvMPhAG0GZbBFRyqm2ZotUDwuYMR9nSHE0JQIw8-qRUvjUCowVDgLyVitHpGBepBPFUs4XH7maQ-werpMLNfdHVekfHs5It4RykSHIkZ-itAwH43qgPB--aZrEaxUsvhAh_qLXp2VMiZLd_Kas61TCo2u4zSM3hgT7A8wCvtCmK6xrnRIocGVzN5-IDrCfJWEOmh1a9tSo8Jv4NPkSsvWAN5EJPgCoaQzvmHj_1n7ptC9GW6nHvHIcXw2aDrdw1xWdGpQWoSAByTtHiTRtuzDDzbvgJZz5XtENYvMbo_4C3-xAjWklsCFLBUYEsbwkoYYsZ9mAFH10S-4sRxIqatl1Kw6NMN2JRjJOKxyp52us20Siu3sO3b8trS4rqWd2dSAkfzcM6qsbepo5mYYPA4J7g0tWHNaKJnqmgIuPtYPSN39gLCb0Uc4Q90Q_PqNf2dVD9GKI8Zjs0XjuyzVMbVu0cgElSLw-Ya0xbBBs4lMruaFM3GqiHNIJotXR4PZADBsOtut56Huu8M4IzY4u3v7ONjleoYdo66yATcEf076u3UgdeD8krM9jUV0sU5xt6oE7ZmcHlrPRYrBfd8XP4F1M8IMR7lDOkEIADmomOVSRFVysoi8a4RQGa8pP4ZP8Vru75i1yEGnZ00QVjVaOz21754QWEUml7er8TBgFMT4rojbbrgew6L3Vd9qpRThavxbM3It_980exeq_pW1XkNJQli7u60nEa3weeiqlKbOXR16pbm985p2cV90jcYBKUU1NRhxfX7iIs_pohGMKC3gfqrInDf273xd9oTyErLDXZNAthY6ejdta0KVUBXMEeSbVUVhH5ItasnOEzjL-z7Hx69LsjoDMWyw_7Sr9NYtSK_N31Fg1f7x7axnti1RmrWzz8gb-cX05dn3ddtYWJnybvYByK8JbaTgVi-SPVejoF4qNPPkLkSicKBk_i6XwNl71F5IpZtPw8hEUsHvNH9VwATxFpfLbNkzdY_v7elYaQ4leI4BPh9G7krbJ49VGVuOnCLqoEw-IL8VxxsMrBzmxA6zS8QJXxLNGXtxoeOOzb2LYHfN9Y5APMFdzg8UQHS7t0r6FxpnaUMCnjLVUq9GPdvUNNtwZNsgqyfoAP18kYu8lzkpd5NgIE-3rCsEYjUIoOMV5xDK5uxErR2GGLUtga8sBvfoUv_VXwcGIDMDIbkI_rYl1g-MTCHqSKuB6L-YfxfIACR7C_7af9eBYTwtXCMWW5kSDdrNrUgqaC-odx1Ci_BnfWE6B-OmgtuidMANs1nBPF6-fXpbhtGStdJEzXnc1gsCH00w_pXM3EgCUmwx_rL-sVnQ_wqkrgNqjTA-p5JgSVYFpZbaLUeVwWEoTTYE3w1ITj1pbk3NaLlMYDw33b85cmM2fHm3p0aM_qX3XPRSH-1F-uOY4KFyhKTTvMMQXR0ZNRtPXEiSJSN0ARPfqqZ7B4Udtc8yEnvKRccoVZ3dkknxFdPdKJk4EKu8pBmPlWeMhnXZzp6oFODLkEsinT0fOe4cQeigZod4VR6fSsgwABYfWUuhh9ihdIjo5Sj0KWjv412khbtbE2BPeLSdZJINXTMoJ3Z_7UmqTaItuOB3p6whFRQCseYldcaI08uUHUH7fyqEKp4bLe6YzBOgcYrMxhr2s7VWomJcJLcg8PLihCErb_Fy7xwQKNHaOGDzBZ9W3BI4skzjlXGzrRB1dCxtUhbJN0WJKyZIKz5FszXwWvSAvM69oFeyoOg3e8R7Tu9zugHaNH7KW_icdgvq3SrcmEPiU4_jcMF8Cn_00Yn4SzozHTDixkF3R1XHx_ULr62h_eIJurVDsE8CccMFdyvx-8RyuLTfwMYV6fD6FAMwG9C4ecJXdRafcHw0qpGSn4xvLpKGoe0fE2CSNjV_X8qdI=",
                "id": "rs_0f7788828722a8db016909294aaf3c81978f511c34dc32b9a2",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 709,
        "prompt_tokens": 129,
        "total_tokens": 838,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 640,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00145025,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.225e-05,
          "upstream_inference_completions_cost": 0.001418
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "In the context of tumorigenesis, which genetic alteration listed below is most likely to lead to copy-neutral loss of heterozygosity, specifically maintaining the gene dosage despite allele deletion?\n\nAnswer Choices:\nA. Mitotic recombination\nB. A deletion of a chromosomal region\nC. Trisomy\nD. Uniparental disomy\nE. Duplication of a chromosomal region"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-83d7dE1LyUSxlvBuFLOE",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. Uniparental disomy is the best choice. In copy\u2011neutral loss of heterozygosity one allele is lost and the remaining allele is duplicated (so total copy number is unchanged) \u2014 somatic uniparental disomy produces this effect (sometimes via mitotic recombination), resulting in homozygosity without net copy-number change.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing genetic alteration mechanisms**\n\nI'm trying to pinpoint which genetic alteration leads to copy-neutral loss of heterozygosity while keeping gene dosage intact despite allele deletion. Copy-neutral LOH happens when one allele disappears, but the other is duplicated, maintaining the normal copy number.\n\nIt seems this often happens through mechanisms like uniparental disomy or mitotic recombination. I'll evaluate options A and D closely, as both mitotic recombination and uniparental disomy can cause this condition in tumorigenesis.**Finalizing the answer for LOH**\n\nI see that the phrase \"despite allele deletion\" directly refers to maintaining gene dosage, which aligns with copy-neutral LOH. This happens through the deletion of one allele and the duplication of the other. Uniparental disomy fits well here since it involves losing one parent's allele while duplicating the other, keeping the count of copies the same. \n\nAlthough mitotic recombination can also lead to similar outcomes, I'll go with D since it emphasizes the classical term of uniparental disomy.**Choosing the explanation for LOH**\n\nI'm gearing up to provide an explanation for copy-neutral loss of heterozygosity. This occurs when one allele is lost, and the other gets duplicated. Uniparental disomy, or somatic UPD, leads to homozygosity while keeping the copy number unchanged. While mitotic recombination can also result in similar outcomes, uniparental disomy seems to be the best choice here. So, I\u2019ll go ahead and state D as my final answer and explain my reasoning clearly.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing genetic alteration mechanisms**\n\nI'm trying to pinpoint which genetic alteration leads to copy-neutral loss of heterozygosity while keeping gene dosage intact despite allele deletion. Copy-neutral LOH happens when one allele disappears, but the other is duplicated, maintaining the normal copy number.\n\nIt seems this often happens through mechanisms like uniparental disomy or mitotic recombination. I'll evaluate options A and D closely, as both mitotic recombination and uniparental disomy can cause this condition in tumorigenesis.**Finalizing the answer for LOH**\n\nI see that the phrase \"despite allele deletion\" directly refers to maintaining gene dosage, which aligns with copy-neutral LOH. This happens through the deletion of one allele and the duplication of the other. Uniparental disomy fits well here since it involves losing one parent's allele while duplicating the other, keeping the count of copies the same. \n\nAlthough mitotic recombination can also lead to similar outcomes, I'll go with D since it emphasizes the classical term of uniparental disomy.**Choosing the explanation for LOH**\n\nI'm gearing up to provide an explanation for copy-neutral loss of heterozygosity. This occurs when one allele is lost, and the other gets duplicated. Uniparental disomy, or somatic UPD, leads to homozygosity while keeping the copy number unchanged. While mitotic recombination can also result in similar outcomes, uniparental disomy seems to be the best choice here. So, I\u2019ll go ahead and state D as my final answer and explain my reasoning clearly.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSlUi-DQHpPTGixtc0qC_AOv5zdY4W0GtrMp0KHKOvwkqsScIYUa9-hGYvv51CELXLvlNDcBptIGL9P6jhtWkh82Vsz6eaQwLxwjaqigL3KElNc8fwE3tpWbhdvYh3BDNajj--JMxQmMQEM9uQNsR08DuGAbbyW4GOKAZJnwzsH5Shi7nYM5O5h6ZBbM1-EIEx3cDWeBwhQ0b-2dJWZ61Xp3d93KGAd84ShomYiAxRqkxys-ErjPJcN_CFJVKUDazb3gtQujezJdDD3mTYmRHOMoX3Wg2a_bt44brxBvrSjJW_uTO9rR9WMPTBb2sDn5h4JCFwaogtrh4gZzNCXAdxOaG748fYtl2jfqTQlxR2jo2BLbL3hEz4-aNlCUNUlE53NLD0KQFQsyLq2bJ8w4SKpPJMVas6o6k4zv24_DKWs_nFsk6Amb2p9QbNU2TJifDBSWZ1FBv3GiT3PVgaXj9sZgW1VwHWklk_Cs60IpSoMZ_1SoliIAqiOoBZwooa2WPzuUFIvHVo-kFmWjPrRZ2GTPyvre8k4HJBBZYJnMn1VXWegzOuU2PCp0m7PignWig_a0Dh_QrwB-G9C9XxkObXcdSElK41NhXUSIUvqRDp4cbX5_bVY1e8MTDpL6X5pHPuII4omgtuM3MKpb2KQfQ3E617-8ppFI_gw9I7Y8oLAcja91EX4MxDsc-8YGaMFUmB8to9JVfDducJeJbxyjbo5_LpIap1xdS1uUGddzmMAS15op2mAnppsSEkVasA4AccV856Wpi7x_OO1c6fenQq1K0ZMKgpJYfiy5JNh57xervWF-at4hi_4v3XKgZtSMbpnn1grMD-YJ_EfMeOlOVgVQj64Ch89UmqORSJzJiMJWNVtvAGdIaxZMVTl83AT2TZylBMVA3YERzEFK6yRsgPhhHM-kfxyqwcu4W9FMQB0MR2rQ44tKHNGtWrLPoGR_FoWiIUTH8wIG4xldVOo9Hso5FEiUcjqgOM-kN68HTA7-IneG03OoyVvxYaWLd8if-B97AOEDRON7J5wvwZaMVzStjjkkl2qQ6JnUIlrK7bvn7ndW0-6xd2GmDt32sulWa72KA-CLCLeyaXQwVao_aFx4nhJU4KBVCLJ-AXgh3ikq7idKd0ctJTU9d9h7SRTODWwdOFvcRLHf90Hb08rm40WO_E2VQeINoUTvshXnNAwPWS8h5PTn68PdzOj9R71anChiB4lUTlQTWZRUcH_ge5IWcdawopOqK475zxVSCC_r0UANiJRYY6LpVrFyWmXgTwzkc4r9p9AgxWiLUvWP7fQSQIL6M38hfsoqNiIYSMujWhr5DSYMk_g5DGGbER1s8AaTS7TEcYGWd0SSb0PidupbxiLsEGL14JFmORg_hN1um0ERVXdqOALJvj12MFfhVFCV4JH4a0zyJ8_XybZGCBZfxYln3M3DG2kTMpkPh9bAnQfCirMujVUQZay5BIYgO0U-lOK99U2GWOX_pGABPE3W9dzETB7OQUxFgPPk1KAfFJhXutYid70UujKzFCMM7x8SoVrLBOf2CydQG0MjnGDH7LcBjVq3IPl9dRS4PVi-Et3KrhVzBm-HOxAsiuQjPlJ0srfsKCWJl7rTRlTPReQph3K93NsL9GWU7k0F2hp2Segy_Gkv7p4bQoha7DYn2mMjSHiINukvsfOlfgL8BiFEbxLmstkU5SQVkzHF65tnW9TS1fLb8IEQFLR06E8GFAgIO9xmEcZqNZUOT4Fl0iLZI7D0QO7g4luMgqV6za06bzCC-oqFbP64n3HqkgHMFPONA8IF2eawYXPwd86a5gVqO_-pE9DeTjBLn7KI2eozUeImOnSjHkJ3okBJpd7svc-JeHN9zeds36RL2_T2vxPYLPq8e2oKBY7CiHIW6WASfvDIb7RicTzvBt6caYlAJeZ8zP63Mz_efcqXzGBbo1NYO-Y3bvYK0xLlKiu1lUTPBhSuqzNB-XZ0jhYhIha2wUotFzhja_X7uCovHcQjN3njMluIPfvMtAmtjL2lGb1f_vkPh1FDm3zjwZrCPMxRjYP9V7Acaf8W241O1r9HDZQ_42Dqhn1gWWnr3qdTH6DIa_LyWSCyAgBSMUp5rJe-vJAWCbk7JKbPSzm0SuYaYSoaJwwEyAPJ7mczH7QE26nY7PgRbnBquzQOM2c9sj95SvYOMO5wAanSQM8cbFYiM34n8u3kBBzAtjrU_-gFuHiFqp8CoRkd4uxa3cYhO65xBbANcX_DtFiACauhYxWwGnEtSpbmSSKbf5ZXDzR8He_mYsRqqSmazoqsMb87rMr2iYi4eIQBw4mcn60AzmgWVAOov-RR_yixVtAZ9vBL1L_dnHCa2YBgzlugnRxTp-UzMWccdJLJH9kfY5I-A_DtucJ870CGSZcnrSgKjx1LfpLi096DU_0BROLheaD6gF7VoJp7hWfGaI-9xImARoRClPygm3JMWx7eDuQBgrgeGNloUIO3XGSDgiDWXSF7KWPQ9SvKlZiNBDJQ43UrLa6NTCm_6DmUcDis1EXh6nlhqF7SK30jG9yX_haoHVhDcsItUSGK8Oo_XIFAW7H34otrCxzRNVwzAX-zplB7FwbIWqJ4Mead5Mu2qcCm70Qcyip_AUv-5we8ktQ_00SkMoJ0pJuh_LQNBPPH5qejcraagnsbBTZP5NKdzMUA2xnu1a0vScJB1w6tg8ETzSLOEBncAr4Tcm1X3yqNxr1yJdmvaV8gJLhuPOPtFe-7VFsHInEy7bZtUuQ01j-jBeepHFKuYCctdS3tWhcDYjtWk6hJP_F2sSNEYvuqF95kdU0udi3PfqcWmjeh14UgyPVTw-PPARO4N2iycKSQgILuoBfJWWX91_kFHs6pPB_JGh4KjKZmA5sXPNG4Y9LfoxBbk_8vqCLRo2n6wav262xJTt9Op6JmXYNms8x1cFCrVi2kkVTXaPg7I5D0GbfKpfXyiWBU7GO7mf_BxTfAdcpFU-lqn1TIB-psrIG2iW7hArRS7Z7y1Tugi2p4GOGro7Mohu5OZBzQETKaGmK5JLOmIyJcHUSnU5_HV2BRooRE9bWMsaa9ZNhKA2MDvN2rAoxDUtp2VBOOikoLgBZCvvUEFkOnXF9Jr-LPGf75nUnZzgcaeYoB2gTNkE8uB_4aV7MOCG18K11aENxfxKHD1L-S7Qs9GJEBGwuIwoLEY-oJuqfkLCof000Ql2ALD2tJc5b2m1OVpJGj9-8gW_71HQHyjcg93sJ0FHEUeVvubms5DlXCBiQ-nUQgp_Yddcl2ICQKiZ9j7Uw0qWYZHlp17-m4djFcFLoy_ZQsFRP5alaZWDGg_31pYEU3l0LBSQN-NO1uCD-HxRq86wzfe9w5rleJ992NdWewQsZfS8dVUM2hR5QV9DeuTMhkeuSrlJrHEnB0xqrQqxRSC_eOLl-h16htnGeebtPeXunYVhuOpcZqZhtCTa681ovSJrpuwdrnOsAfafl7WJUqoWLH5-FKk1gfnzmEyprLtPJTJ5JFS4lZJe1LSMD3MkJNG0aSDkz6t6-a2kARCzILINLrJz898A8rNAEjqs9IUfNn82539FlfkvfoEsZHpf70HFrwVbdR6WVVKWquRMvtVemuKghQoJg7rc1B1mMb7b8WOK6igSI3jYsV3jI7KJg_vPIEh9_U8nBmKRRQx_1lPPMhBf1_VYwgMenVitQzn-DCA-tVuQnbdd38GfnmKoUZAX3kvdflKq1sbUsEPOAGH4ZmbS16OMwh4W6a8YYelqwFgQJJn9gXMA3bLMJA7ASsF8wDo9ws0q9G5-34ldtJKE3FBztnymdeCtY1FNtnjPz5YivVGc0rsNvFMGXWuMRNv6RzPUgjlAtV4brcrEmdjE7eLzgmZI6JDugSpA7JUMRI8AqaqR0_raT4uHbK4_oS",
                "id": "rs_0ae15c672a693bde016909294a4ac08197b4f5519233dd76d1",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 538,
        "prompt_tokens": 129,
        "total_tokens": 667,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 448,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00110825,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.225e-05,
          "upstream_inference_completions_cost": 0.001076
        }
      },
      "provider": "OpenAI"
    }
  }
]